Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Peintinger Florentia |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Banys-Paluchowski, M; Basali, T; Hartmann, S; de Boniface, J; Gentilini, OD; Stickeler, E; Mau, C; Ruf, F; Froehlich, S; Gasparri, ML; Thill, M; Peintinger, F; Cakmak, GK; Rubio, IT; Langanke, D; Ovalle, SC; Riemer, S; Rody, A; Schlichting, E; Kuehn, T
Radar reflectors for marking of target lymph nodes in patients receiving neo-adjuvant chemotherapy for breast cancer: A subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
J CLIN ONCOL. 2024; 42(16):
[Poster]
Web of Science
Banys-Paluchowski, M; Hartmann, S; de Boniface, J; Gentilini, OD; Basali, T; Stickeler, E; Untch, M; Ruf, F; Fröhlich, S; Thill, M; Lux, MP; Peintinger, F; Cakmak, GL; Rubio, I; Kontos, M; Di Micco, R; Murawa, D; Schlichting, E; Sezen, BA; Rody, A; Langanke, D; Bündgen, N; Sanchez-Mendez, JI; Buss-Steidle, R; Mau, C; Buchmann, N; Riemer, S; Hansen, MH; Ditsch, N; Kühn, T
(PO3-23-03) Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
San Antonio Breast cancer Symposium; DEC 5-9, 2023; San Antonio, TEXAS, USA. 2023.
[Poster]
Banys-Paluchowski, M; Kühn, T; Masannat, Y; Ditsch, N; Esgueva, A; Cabıoğlu, N; Murawa, D; Canturk, NZ; Rubio, I; de Boniface, J; Karakatsanis, A; Dave, R; Potter, S; Kothari, A; Gentilini, OD; Weber, W; Krawczyk, N; Hartmann, S; Cakmak, GK; Hahn, M; Lux, MP; Tvedskov, T; Pankratjevaite, L; Kontos, M; Peintinger, F; Lowery, A; Smidt, M; Rebaza, L; Vasconcelos, M; Gulluoglu, BM; Sezen, BA; Di Micco, R; Nietz, S; Malherbe, F; Gasparri, ML; Alran, S; Deo, SVS; Khan, MM; Harvey, J
(PO4-18-12) MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4 / iBRA-NET, NCT 05559411)
San Antonio Breast Cancer Symposium; DEC 5-9, 2023; San Antonio, TEXAS, USA. 2023.
[Poster]
Peintinger, F; Kühn, T; Kolberg, HC; Reitsamer, R; Schmatloch, S; Sieghartsleitner, E; Du, L; Berghold, A; Fraser Symmans, W
(PO5-22-12) Development and Validation of a Genomic Test to Predict Tumor Response of the Axillary Nodes after Neoadjuvant Chemotherapy (NAC) in Patients with HER2-negative Breast Cancer: Results of the AGO-35 trial
San Antonio Breast Cancer Symposium; DEC 5-9, 2023; San Antonio, Texas, USA. 2023.
[Poster]
Peintinger, F; Sieghartsleitner, E; Pfeifer, B; Pristauz-Telsnigg, G; Tsangarakis, G; Hochstätter, R; Koller, R; Denison, U; Hager, C; Reitsamer, R
(PO5-22-11) Radiotherapy-associated Complications in Breast Cancer patients treated with Nipple-Sparing Mastectomy: Results of the Reconstruction-after-Mastectomy AGO R02 Registry.
San Antonio Breast Cancer Symposium; DEC 5-9, 2023; San Antonio, TEXAS, USA. 2023.
[Poster]
Reimer, T; Gerber, B; Kuehn, T; Bangemann, N; Kleine-Tebbe, A; Stefek, A; Doerste, U; Hammerle C; Hoffmann, o; Hein, A; Rubio, I; Peintinger, F; Mehta, K; Loibl, S; Botteri, E; Gentilini, O
(PO5-18-10) Omission of SLNB in triple-negative and HER2-positive breast cancer patients with radiologic and pathologic complete response in the breast after NAST: a single-arm, prospective surgical trial (EUBREAST-01 trial, GBG 104)
San Antonio Breast Cancer Symposium; DEC 5-9, 2023; San Antonio, TEXAS, USA. 2023.
[Poster]
Reitsamer, R; Sir, A; Forsthuber, E; Peintinger, F
(PO5-23-02) Targeted Axillary Dissection with Paramagnetic Marker Localization
San Antonio Breast Cancer Symposium; DEC 5-9, 2023; San Antonio, Texas, USA. 2023.
[Poster]
Banys-Paluchowski, M; Hartmann, S; Stickeler, E; De Boniface, J; Gentilini, O; Frohlich, S; Thill, M; Ruf, F; Hauptmann, M; Cakmak, GK; Rubio, IT; Gasparri, ML; Kontos, M; Bonci, EA; Niinikoski, L; Di Micco, R; Murawa, D; Pinto, D; Peintinger, F; Dostalek, L; Solbach, C; Appelgren, M; Blohmer, JU; Thiemann, E; Weigel, M; Kaltenecker, G; Ramaker, K; Schrauder, MG; Kuhn, T
AXSANA - EUBREAST 3 (AXillary Surgery After NeoAdjuvant Treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)
ONCOL RES TREAT. 2022; 45(SUPPL 3):24-25.
[Onlinepräsentation]
Web of Science
Rief, A; Kuhn, T; Peintinger, F; Hartmann, S; Stickeler, E; de Boniface, J; Gentilini, O; Ruf, F; Frohlich, S; Thill, M; Hauptmann, M; Berger, T; Wihlfahrt, K; Cakmak, GK; Rubio, TI; Gasparri, LM; Kontos, M; Bonci, EA; Niinikoski, L; Murawa, D; Appelgren, M; Hahn, M; Pristauz-Telsnigg, G; Czihak, J; Banys-Paluchowski, M
AXSANA - AXillary Surgery After NeoAdjuvant Treatment: A prospective, multicenter Cohort Study by the EUBREAST Study Group to evaluate different surgical Procedures of axillary Staging in initially node-positive Patients after neoadjuvant Chemotherapy
GEBURTSH FRAUENHEILK. 2022; 82(6): S47-S48.
Doi: 10.1055/s-0042-1750235
[Poster]
Web of Science
FullText
FullText_MUG
Sieghartsleitner, E; Sunitsch, S; Rief, A; Regitnig, P; Geigl, J; Tamussino, K; Peintinger, F
Somatic gene alterations in endometrial cancer and correlation with germline alterations
GEBURTSH FRAUENHEILK. 2022; 82(10):E162-E163.
Doi: 10.1055/s-0042-1757051
[Poster]
Web of Science
FullText
FullText_MUG
Sieghartsleitner, E; Sunitsch, S; Rief, A; Regnitnig, P; Geigl, J; Tamussino, K; Peintinger, F
Somatic Gene Changes in Endometrial Cancer and Correlation with Germline Changes
GEBURTSH FRAUENHEILK. 2022; 82(6):S48-S49.
Doi: 10.1055/s-0042-1750237
Web of Science
FullText
FullText_MUG
Pischler, C; Beichler, C; Pristauz, G; Trapp, EK; Peintinger, F; Weirather, C; Siebenhofer, C; Petru,E; Geigl, J; Heitzer, E; Speicher, M
Identification of biomarkers from plasma-DNA from patients with ovarian cancer
Doctoral Day 2021; FEB 12, 2021; Virtual Congress, Graz, AUSTRIA. 2021.
[Onlinepräsentation]
Sieghartsleitner, E; Sunitsch, S; Regitnig, P; Tamussino, K; Geigl, J; Peintinger, F
Survey of somatic Gene Changes in Patients with Endometrial Cancer and Correlation with Germline Alterations
GEBURTSH FRAUENHEILK. 2021; 81(06):E28-E28.
Doi: 10.1055/s-0041-1730510
[Poster]
Web of Science
FullText
FullText_MUG
Sieghartsleitner, EA; Sunitsch, S; Regitnig, P; Tamussino, K; Geigl, J; Peintinger, F
Survey of somatic Gene Changes in Endometrial Cancer and Correlation with Changes in the Germline
GEBURTSH FRAUENHEILK. 2021; 81(04):E7-E7.
Doi: 10.1055/s-0041-1726595
[Poster]
Web of Science
FullText
FullText_MUG
Peintinger F
Früherkennung - Mammakarzinom.
Jahrestagung OEGGG; Sept 7-9, 2020; Online. 2020.
[Oral Communication]
Peintinger F
Sentinellymphknotenbiopsie-was ist noch unklar?
BGGF/OEGGG Kongress 2019; Sept 12-14, 2019; Munich, GERMANY. 2019.
[Oral Communication]
Peintinger F
Optimal duration of endocrine therapy in breast cancer
13th Congress of the European Society of Gynecology; Oct 16-19, 2019; Vienna, AUSTRIA. 2019.
[Oral Communication]
Klaassen-Federspiel, F.; Pristauz, G.; Sieghartsleitner, E.; Koller, R.; Sir, A.; Reitsamer, R.; Peintinger, F
AGO R02 Brustrekonstruktion nach Mastektomie – Register zur prospektiven und retrospektiven Erfassung und Dokumentation von Brustrekonstruktionen nach Nipple- Sparing-Mastektomie
Breast Care 2018;13:456–462 DOI: 10.1159/000495633. 2018; -Jahrestagung der Österreichischen Gesellschaft für Senologie; SEP 27-29, 2018; Graz, AUSTRIA.
[Oral Communication]
Nanda M., Peintinger F., Sieghartsleitner E., Klaassen F., Reitsamer R., Kolberg H.C., Schwatloch S., Kühn T
Accuracy of surgical opinion case report forms to predict type of
axillary surgery after neoadjuvant chemotherapy in theAGO-35 trial
38. Jahrestagung der Deutschen Gesellschaft für Senologie; June 14-16, 2018; Stuttgart, GERMANY. 2018.
[Poster]
Peintinger F
Die propylaktische Salpingoorphoektomie: Wer, wann und wie? - Prophylactic salpingoorphorectomy: Who, when and how?
38. Jahrestagung der Deutschen Gesellschaft für Senologie; June 14-16,2018; Stuttgart, GERAMNY. 2018.
[Oral Communication]
Peintinger F
Translationale Fragestellungen für Lymphknotenstudien
38. Jahrestagung der Deutschen Gesellschaft für Senologie; June 14-16,2018; Stuttgart, GERMANY. 2018.
[Oral Communication]
Sieghartsleitner, E.; Peintinger, F.; Manurishi, N.; Klaassen, F.; Reitsamer, R.; Kolberg, H.-C.; Schmatloch, S.; Kühn, T.; AGO 35
Accuracy of Surgical Opinion Case Report Forms to Predict Type of Axillary Surgery after Neoadjuvant Chemotherapy in the AGO-35 Trial
Breast Care 2018;13:456–462 DOI: 10.1159/000495633. 2018; -Jahrestagung der Österreichischen Gesellschafter Senologie; SEP 27-29, 2018; Graz, AUSTRIA.
[Poster]
Kammerer, S; Jahn, S; Winter, E; Sokolowski, A; Hackl, H; Platzer, D; Peintinger, F; Schreibmayer, W; Bauernhofer, T
GIRK1: a new prognostic biomarker for estrogen receptor positive breast cancer
OeGHO Frühjahrstagung 2015; APR 23-25, 2015; Salzburg, AUSTRIA. 2015.
[Poster]
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, SW; Peintinger, F; Symmans, F; Schreibmayer, W; Bauernhofer, T.
GIRK1 overexpression correlates with ER positive breast cancer subtypes and is associated with poor prognosis.
Annals of Oncology 2015;26(Supplement 3):15-24. 2015; 26(Supplement 3): 22--IMPAKT 2015 Breast Cancer Meeting; MAY 7-9, 2015; Brussels, BELGIUM.
[Poster]
Kühn, T; Schermann, C; Regitnig, P; Moinfar, F; Symmans, WF; Peintinger F
AGO Austria-35: Prospektive Validierung der genomischen Signaturen zur Erfassung der Chemosensitivität der axillären Lymphknoten nach neoadjuvanter Chemotherapie beim HER2 negativem Mammakarzinom
35. Jahrestagung der Deutschen Gesellschaft für Senologie ; JUNE 25-27, 2015; Leipzig, Germany. 2015.
[Poster]
Peintinger F
Was ist bei jungen Frauen mit Mammakarzinom zu bedenken?
14. Internationaler Maritimer Kongress; MAI 10-15, TÜRKEI; BELEK, TÜRKEI. 2015.
[Oral Communication]
Peintinger F
Mammakarzinom der älteren Frau- Systemtherapie
14. Internationaler Maritimer Kongress; MAI 10-15, 2015; Belek, Türkei. 2015.
[Oral Communication]
Peintinger F, Kühn T, Schermann C, Regitnig P, Moinfar F, Sauseng S, Symmans W
AGO Austria-35: Prospektive Validierung der genomischen Signaturen zur Erfassung der Chemosensitivität der axillären Lymphknoten nach neoadjuvanter Chemotherapie beim HER2 negativem Mammakarzinom.
Senologie-Zeitschrift für Mammadiagnostik und -therapie 2015; 12 - A113. 2015; -Jahrestagung Deutsche Gesellschaft für Senologie ; Jun 25-27, 2015; Leipzig.
[Poster]
FullText
Peintinger, F; Zurl, B; Fastner, G; Sedlmayer, F; Schermann, C; Reitsamer, R
Low Locoregional Recurrence Rates After Neoadjuvant Therapy Followed by Small Surgical Resection Volume and Intraoperative Radiotherapy
ANN SURG ONCOL. 2015; 22: 87-87.-16th Annual Meeting of the American-Society-of-Breast-Surgeons; APR 29-MAY 03, 2015; Orlando, FL.
Doi: 10.1093/annonc/mdu068.2
[Poster]
Web of Science
FullText
FullText_MUG
Schermann C, Kühn T , Regitnig P, Moinfar F , Vagena F , Bjelic-Radisic V, Schrenk P , Peintinger F
Übereinstimmung des Tumoransprechens mittels RCB (Residual Cancer Burden) und Radiodiagnostik nach neoadjuvanter Chemotherapie
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2015; 12 - A122. 2015; -JahrestagungDeutsche Gesellschaft für Senologie; Jun 25-27, 2015; Leipzig, Germany.
[Poster]
FullText
Schermann, C; Kühn, T; Regitnig, P; Moinfar, F; Vagena,F; Bjelic-Radisic, V; Schrenk, P; Peintinger F
Übereinstimmung des Tumoransprechens mittels RCB (Residual Cancer Burden) und Radiodiagnostik nach neoadjuvanter Chemotherapie
35. Jahrestagung der Deutschen Gesellschaft für Senologie ; JUNE 25-27, 2015 ; Leipzig, Germany. 2015.
[Poster]
Kammerer, S; Sokolowski, A; Hackl, H; Jahn, S; Asslaber, M; Symmans, F; Peintinger, F; Regitnig, P; Schreibmayer, W; Bauernhofer, T
OVEREXPRESSION OF G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 1 (GIRK1) IS ASSOCIATED WITH LYMPH NODE METASTASIS AND POOR PROGNOSIS IN BREAST CANCER
ANN ONCOL. . 2014; 25: -IMPAKT Breast Cancer Conference; MAY 08-10, 2014; Brussels, BELGIUM.
Doi: 10.1093/annonc/mdu066.21
[Poster]
Web of Science
FullText
FullText_MUG
Klaasen-Federspiel, F; Schmied, T; Peintinger, F; Reitsamer, R.
Technical results and complication rates after nipple-sparing mastectomy and direct-to-implant breast reconstruction using porcine acellular dermal matrix for implant coverage
Joint Swiss and Austrian Society of Senology Congress-Senoforum 2014; Sep 11-12, 2014; Lugano, Switzerland. 2014.
[Poster]
Reitsamer, R; Schmied, T; Klaassen-Federspiel, F;Peintinger,F.
Prepectoral implant placement and complete coverage with porcine acellular dermal matrix (ADM): a technique dor direkt-to-implant breast reconstruction after nipple-sparing mastectomy (NSM)
Joint Swiss and Austrian Society of Senology Congress-Senoforum 2014; Sep 11-12, 2014; Lugano, Switzerland. 2014.
[Poster]
Schermann, C; Zurl, B; Regitnig,P; Moinfar, F; Symmans, FW; Bjelic-Radisic, V; Schrenk, P; Peintinger, F.
Agreement between predicted response by imaging methods and pathological response by RCB in breast cancer patients treated with neoadjuvant chemotherapy.
Ann Oncol (Suppl). 2014; -IMPAKT 2014 Breast Cancer Conference; MAY 8-10,2014; Brussels, BELGIUM.
[Poster]
Fastner, G; Reitsamer, R; Menzel, C; Fischer, T; Kopp, M; Peintinger, F; Sedlmayer, F.
IOERT und Ganzbrustbestrahlung nach neoadjuvanter Chemotherapie beim brusterhaltend operierten Mammakarzinom: 5-Jahres-Resultate einer retrospektiven Analyse
Strahlenther Onkol 2013 · 189 (2):176–177. 2013; 189(2):-29. Jahrestagung der Österreichischen Gesellschaft für
Radioonkologie, Radiobiologie und Medizinische Radiophysik (ÖGRO 2012); SEP 28-29, 2012; Gmunden, AUSTRIA.
[Poster]
Greggi, S; du Bois,A ; Selle, F; , Reu, A; Åvall-Lundqvist, E; Vergote, I; Raspagliesi,F; Zang, R; Ponce, J; Lueslely, D; Peintinger,F, et al.
Cytoreductive Surgery in recurrent ovarian cance. The DESKTOP series of the AGO study group, NOGGO, MITO, MANGO, GEICO, NSGO, AGO-AUSTRIA, SGOG, CRCTU, BGOG AND GINECO
Volume 23, October 2013, Supplement 18, pp. 134. 2013; -18th international meeting of the european society of gynecological oncology; Oct 19-22, 2013; Liverpool, England.
[Poster]
Gschwandtner, E;, Reitsamer, R; Farmini, A; Schmied, T;
Peintinger, F; Fischer,T.
Sexual Function in Breast Cancer Patients
Jahrestagung der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe; MAI 29-JUN 1, 2013; Innsbruck, AUSTRIA. 2013.
[Poster]
Parvizi,D; Hass, F; Peintinger, F; Hubmer, M; Rappl, T; Spendel, S; Koch, H; Kamolz, LP; Weinke, R
Erste Erfahrungen zur Beurteilung der Vaskularisation und Integration von azellulärer Gewebematrix (ADM) nach Implantat-basierter Brustrekonstruktion und Implantatabdeckung mittels ADM durch kontrastmittelverstärkte Sonographie (CEUS).
Abstractband. 2013; -51. Jahrestagung der ÖGPÄRC; OKT 23-5, 2013; Velden, AUSTRIA. (ISBN: 978-3-7011-7882-7 )
[Oral Communication]
Peintinger, F
Genomischer Test für das Tumoransprechen der axillären
Lymphknoten nach neoadjuvanter Chemotherapie.
Jahrestagung der Österreichischen Gesellschaft für Senologie; SEP 26-28,2013; Velden, AUSTRIA. 2013.
[Oral Communication]
Peintinger F.
Systemische Therapie- Patientinnen < 35 J und > 70 J mit befallenen Lymphknoten
13. Internationaler Maritimer Kongress SENOLOGIE 2013; MAY 19 - 25, 2013 ; Belek, TURKEY. 2013.
[Oral Communication]
Peintinger F.
Screening und Früherkennungsprogramme
XXII. Wissenschaftliche Tagung der Arbeitsgemeinschaft für
gynäkologische Onkologie; APR 11-13, 2013; Salzburg, AUSTRIA. 2013.
[Oral Communication]
Peintinger F.
Vergleich der Wundinfektionsraten mit und ohne konventionellem Wundmanagement nach operativer Therapie des Mammakarzinoms
Jahrestagung der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe; MAI 29-JUN 1, 2013; Innsbruck, AUSTRIA. 2013.
[Poster]
Peintinger F.
HRT und Brustkrebs: Was gibt es Neues?
13. Internationaler Maritimer Kongress SENOLOGIE 2013; MAY 19 - 25, 2013; Belek, TURKEY. 2013.
[Oral Communication]
Sarcletti, J; Peintinger,F; Fischer,T; Bogner, G.
Trabectedine treatment in advanced gynecological cancer - experience and results
Vol 23, Oct 2013, Suppl 18, pp 523. 2013; -18th International meeting of the european society of gynaecological oncology; Oct 19-22, 2013; Liverpool, England.
[Poster]
Schermann, C;Regitnig,P; Moinfar, F; Vagena, F; Bjelic-Radisic, V; Schrenk,P; Peintinger,F.
Übereinstimmung des Tumoransprechens mittels RCB und Radiodiagnostik nach neoadjuvanter Chemotherapie
Jahrestagung der Österreichischen Gesellschaft für Senologie; SEP 26-28,2013; Velden, AUSTRIA. 2013.
[Poster]
Schmied, B; Reitsamer R; Fischer, T; Kronberger, ;Peintinger, F.
Metaplastisches Mammakarzinom: Zwei Fallberichte und Review der Literatur
Jahrestagung der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe; MAI 29-JUN 1, 2013; Innsbruck, AUSTRIA. 2013.
[Poster]
Schmied,B; Reitsamer, R; Fischer, T;Kronberger,C; Peintinger,F.
Metaplastisches Mammakarzinom
Jahrestagung der Österreichischen Gesellschaft für Senologie; SEP 26-28,2013; Velden, AUSTRIA. 2013.
[Poster]
Fastner, G; Reitsamer, R; Menzel, C; Fischer, T; Kopp, M; Peintinger, F; Sedlmayer, F.
IOERT und Ganzbrustbestrahlung nach neoadjuvanter Chemotherapie beim brusterhaltend operierten Mammakarzinom: Eine retrospektive Analyse
Geburtsh Frauenheilk 2012; 72: A17. 2012; 72: -29. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie,
Radiobiologie und Medizinische Radiophysik; SEP 28-29,2012; Gmunden, AUSTRIA.
[Oral Communication]
Peintinger F.
UPDATE Chemotherapie und neue Therapieansätze in der Behandlung des Mammakarzinoms
Herbsttagung der ÖSTERREICHISCHEN GESELLSCHAFT FÜR
GYNÄKOLOGIE UND GEBURTSHILFE; Oct 27-Nov 3, 2012; Teneriffa, SPAIN. 2012.
[Oral Communication]
Peintinger F.
RANK Ligand Inhibition in der Osteo-Onkologie
Wissenschaftliche Tagung der Arbeitsgemeinschaft für gynäkologische Onkologie; APR 19-21, 2012; Salzburg, AUSTRIA. 2012.
[Oral Communication]
Peintinger F.
Biological Agents
Neue Therapiemöglichkeiten beim metastasierten Mammakarzinom, Brustzentrum Graz; Nov 5, 2012; Graz, AUSTRIA. 2012.
[Oral Communication]
Peintinger F.
Einfluss von Chemosensitivität und pathologisches Ansprechen
Jahrestagung der Österreichischen Gesellschaft für Senologie
; SEP 27-28, 2012; Vienna, AUSTRIA. 2012.
[Oral Communication]
Peintinger F.
Krebs und Fertilität der jungen Frau
Jahrestagung der Österreichischen Gesellschaft für Senologie; SEP 27-28, 2012; Vienna, AUSTRIA. 2012.
[Oral Communication]
Symmans, WF; Andreopoulou, E; Booser, DJ; Hatzis, C; Wallace, MJ; Zhang, Ya; Gong, Y; Ignatiadis, M; Sotiriou, C; Andre, F; Peintinger, F; et al.
Progression of genomic signatures in local and metastatic estrogen receptor-positive (ER+) breast cancer: Relevance to palliative treatment.
J Clin Oncol 30, 2012 (suppl; abstr 515). 2012; -ASCO Annual Meeting; Juni 1-5, 2012; Chicago, USA.
[Poster]
Peintinger F.
Mammakarzinom der jungen Frau
12. Internationaler Maritimer Kongress - Senologie 2011 ; 2011; Krete, GREECE. 2011.
[Oral Communication]
Symmans, WF;Andre, F;Liu, MC;Delacruz, J;Peintinger F, et al.
Blinded validation study of genomic predictions for survival following adjuvant sequential anthracycline docetaxel chemotherapy with or without endocrine therapy
Supplememt
J Clin Oncol 29: 2011 (suppl; abstr 1030). 2011; -ASCO Annual Meeting; June 3-7, 2011; Chicago, USA.
[Poster]
Peintinger, F; Mazouni, C; Stranzl, H; Ralph, G; Reitsamer, R
Micrometastases in sentinel lymph nodes in patients with breast carcinoma: indication for chemotherapy.
GEBURTSH FRAUENHEILK. 2010; 70(5):P51--Jahrestagung der OEGGG 2010 ; 2.-5. Juni 2010; Zell/See.
[Poster]
Web of Science
Peintinger, F; Mazouni, Ch; Stranzl, H; Ralph, G; Reitsamer, R
Mikrometastasen in Sentinel Lymphknoten bei Patientinnen mit Mammakarzinom: Indikationsstellung zur Chemotherapie
Zeitschrift der OEGG2010; -Jahrestagung der OEGGG
; 02.-05.Juni 2010; Zell am See, Austria.
[Poster]
Pittler, P ; Peintinger, F ; Naglis, R ; Ralph, G.
Desmoplastic Malignant Melanoma of the Breast: a case report.
GEBURTSHILFE UND FRAUENHEILKUNDE 70 (5):427-427. 2010; 70(5):427-427.-Jahrestagung der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe; JUN 2-5, 2010; Zell am See, AUSTRIA.
[Poster]
Reitsamer, R ; Glueck, S ; Menzel, C ; Peintinger, F.
Sentinel Lymph Node Biopsy After Primary Systemic Therapy
ANNALS OF SURGICAL ONCOLOGY 17 (2):S158. 2010; 17(2):158--Annual Meeting, American Society of Breast Surgeons; APR 2-MAY2, 2010; Las Vegas, USA.
[Poster]
Reitsamer, R; Kopp, M ; Fastner, G ; Menzel, C ; Glueck, S ; Merz, F ; Kopp, P ; Deutschmann, H , ; Peintinger, F ; Sedlmayer, F
10-year results of intraoperative electron radiotherapy (IOERT) in boost modality in breast cancer patients treated with breast conserving surgery
European Journal of Cancer 8 (3): 128. 2010; 8(3):128-- European Breast Cancer Conference; MAR 24–27, 2010; Barcelona, SPAIN.
[Poster]
Steger, GG; Mlineritsch, B; Bartsch, R; Pluschnig, U; Petru, E; Peintinger, F; Sevelda, P; Greil, R
Non-pegylated liposomal doxorubicin in metastatic breast cancer (MBC) - Results from an Austrian post marketing surveillance programme
ONKOLOGIE. 2010; 33: 55-55.
[Keynote lecture]
Web of Science
Peintinger, F; Litscher, B; Frank, K; Schmolzer, L; Ralph, G; Stranzl, H
Reduction of wound infection rate after operative therapy of breast carcinoma with hydrofiber/foil- combination dressing in wound management
GEBURTSH FRAUENHEILK. 2009; 69(5):P141--OEGGG 2009; 10.-13 Juni 2009; Wien.
[Oral Communication]
Web of Science
Peintinger F, Stranzl H, Mazouni C, Garbay J, Delaloge S, Reitsamer R
Characteristics of breast cancer patients with micrometatastatic disease in the sentinel lymph node treated with or without chemotherapy
Breast Cancer Symposium 2009; 8-10th October 2009; San Antonio, US. 2009.
[Oral Communication]
Reitsamer, R; Glueck, S ; Menzel, C ; Peintinger, F.
Non-Sentinel Lymph Node Status of Patients with T1/T2 Breast Cancer and Micrometastasis in the Sentinel Lymph Node.
CANCER RESEARCH 69 (24) 549S Supplement: 3. 2009; 69(24):549--San Antonio Breast Cancer Symposium; DEC 10-13, 2009; San Antonio, USA.
[Poster]
Hubbard, R; Peintinger, F ; Liedtke, C ; Hatzis, C ; Kuerer, HM; Valero, V ; Buzdar, AU ; Hortobagyi, GN ; Pusztai, L ; Symmans, WF
Prognostic value of residual cancer burden after neoadjuvant taxane-anthracycline chemotherapy in phenotypic subsets of breast cancer
JOURNAL OF CLINICAL ONCOLOGY 2008, 26(15)
Meeting Abstract: 544. 2008; 26(15):-Annual Meeting AMERICAN SOCIETY CLINICAL ONCOLOGY; MAY 30- 3 JUN, 2008; Chicago, USA.
[Poster]
Peintinger, F; Regitnig, P; Leitner, G; Ralph, G; Stranzl-Lawatsch, H
Prognosis of patients with small, nodal negative mamma carcinoma in association to hormone receptor and HER2-Expression
GEBURTSH FRAUENHEILK. 2008; 68(4):433-434.
[Oral Communication]
Web of Science
Peintinger,F; Hatzis, C; Morkowski, J; Hubbard,R.; Albarracin, C. T; Qureshi, G; Pusztai,L; Symmans,WF.
Inter-pathologist agreement of residual cancer burden (rcb) assessment in breast cancer after treatment with preoperative chemotherapy
Journal of Clinical Oncology Annual Meeting Proceedings.
26 ( 20 Supplement), 2008: 576. 2008; 26(15):576--Annual Meeting American Society of Clinical Oncology
2008 ; MAY 30- 3 JUN, 2008; Chicago, USA.
[Poster]
Rakkhit, R; Broglio, K ; Peintinger, F ; Cardoso, F ; Hanrahan, EO ; Litton, JK ; Sahin, A ; Larsimont, D ; Meric-Bernstam, F ; Buchholz, TA ; Valero, V (Valero, V.); Theriault, RL ; Piccart, M ; Ravdin, P ; Hortobagyi, GN ; Gonzalez-Angulo, AM
Significant increased recurrence rates among breast cancer patients with HER2-positive, T1a,bN0M0 tumors
CANCER RESEARCH 2009, 69 (2): 98S-98S. 2008; 69(2):98--San Antonio Breast Cancer Conference; DEC 10-14, 2008; San Antonio, USA.
[Poster]
Reitsamer, R ; Menzel, C ; Gluck, S ; Schlederer, E ; Wilhelm, C ; Peintinger, F
The feasibility of sentinel lymph node biopsy in breast cancer patients after primary systemic therapy
GEBURTSHILFE UND FRAUENHEILKUNDE 2009, 68 (suppl 1): S29-S29 . 2008; 68: S29--Jahrestagung der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe; MAI 21. – 24, 2008 ; Dornbirn, AUSTRIA.
[Poster]
Reitsamer, R.; Glueck, S ; Schlederer, E ; Wilhelm, C ; Menzel, C ; Peintinger, F
The accuracy of sentinel node biopsy after primary systemic therapy is comparable with the results of sentinel node biopsy in breast cancer patients with primary surgery
European Journal of Cancer 2008, 6 (7) SUPPLEMENTS:150-150. 2008; 6(7):150--European Breast Cancer Conference; APR 15–19 , 2008; Berlin, GERMANY.
[Poster]
Reitsamer, R; Sedlmayer, F ; Menzel, C ; Glueck, S ; Kopp, M ; Peintinger, F.
Ipsilateral breast tumor recurrence rates in breast cancer patients treated with preoperative chemotherapy, breast conserving surgery and intraoperative radiotherapy with electrons
CANCER RESEARCH 2009, 69 (2) : 347S-347S. 2008; 69(2):347--San Antonio Breast Cancer Symposium; DEC 10-14, 2008; San Antonio, USA.
[Poster]
Stranzl-Lawatsch, H; Regitnig, P; Peintinger, F
Female patients with low-risk mamma carcinoma and HER2-new status
STRAHLENTHER ONKOL. 2008; 184: 65-65.
[Oral Communication]
Web of Science
Stranzl-Lawatsch, H; Regitnig P, Peintinger F
Patientinnen mit low-risk Mammakarzinom und HER2-neu Status
abstraktband2008; 184(S1):65-65.-ÖGRO -DEGRO; 1.-4. Mai 2008; Wien.
[Oral Communication]
Mazouni,C; Peintinger, F; Wan-Kau, S; Andre, F; Gonzalez-Angulo, A. M; Symmans, F; Meric-Bernstam, F; Valero,V; Hortobagyi, G; Pusztai L.
Effect on patient outcome of residual DCIS in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy
Journal of Clinical Oncology, 2007 Meeting Proceedings
Vol 25, No 18S (June 20 Supplement): 530
. 2007; 25: -2007 Annual Meeting American Society of Clinical Oncology ; JUN 1-5, 2007; Chicago, USA.
[Poster]
Mazouni,C; Peintinger, F; Wan-Kau, S; Andre,F; Gonzalez-Angulo, A. M; Symmans,F; Meric-Bernstam,F; Valero,V; Hortobagyi,G.; Pusztai L.
Effect on patient outcome of residual DCIS in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy
Journal of Clinical Oncology, Meeting Proceedings
Vol 25, No 18S (June 20 Supplement), 2007: 530. 2007; 25: -Annual Meeting American Society of Clinical Oncology; JUN 1-5, 2007; Chicago, USA.
[Poster]
Peintinger, F; Leitner, G, Ralph, G; Stranzl, H
Survival of patients with small HER2 positive, node negative breast cancer and implications for treatment with trastuzumab
Tagungsband2007; 215--Joint Meeting of the Slovenian and Austrian Society of Senology; 13.-15. September 2007; Graz.
[Oral Communication]
Peintinger, F; Leitner, G, Ralph, G; Stranzl, H
Comparison of quality of life and arm complaints after axillary lymph node dissection versus sentinel lymph node biopsy in breast cancer patients
Tagungsband2007; 207--Joint Meeting of the Slovenian and Austrian Society of Senology; 13.-15. September 2007; Graz.
[Oral Communication]
Peintinger,F; Buzdar, A;Kuerer, H ;Gonzalez-Angulo,A ; Hatzis, C; Pusztai, L; Esteva, F;Green, M ; Hortobagyi, G; Symmans WF.
The impact of hormone receptor status on pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy with or without trastuzumab
Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings 25, No 18S (June 20 Supplement), 2007: 533
© . 2007; 25: - Annual Meeting American Society of Clinical Oncology 2007; JUN 1-5, 2007; Chicago, USA.
[Poster]
Hatzis, C; Peintinger, F ; Valero, V ; Booser, DJ ; Mejia, J ; Hortobagyi, GN ; Pusztai, L ; Symmans, WF
Genomic predictor of benefit from endocrine therapy also predicts response to chemotherapy.
BREAST CANCER RESEARCH AND TREATMENT 2006, 100 (1 suppl): S134-S134. 2006; 100: 134--San Antonio Breast Cancer Symposium; DEC 14–17, 2006; San Antonio, USA.
[Poster]
Mazouni, C; Hall, A ; Anderson, K ; Peintinger, F ; Frische, H ; Andre, F ; Yekell, S ; Arun, B ; Buzdar, AU ; Esteva, F ; Pusztai, L ; Cristofanilli, M
An early decrease in serum HER-2/neu levels after initiation of primary chemotherapy for HER-2 positive breast cancer indicates response to treatment.
BREAST CANCER RESEARCH AND TREATMENT 2006, 100(Supplement 1) S51-S51 . 2006; 100: S51--San Antonio Breast Cancer Symposium; DEC 14–17, 2006; San Antonio, USA.
[Poster]
Peintinger, F; Anderson, K ; Mazouni, C ; Kuerer, HM ; Symmans, WF ; Pusztai, L
Correlation between residual cancer volume and MDACC genomic response predictor score in breast cancer patients treated with preoperative chemotherapy.
BREAST CANCER RESEARCH AND TREATMENT 2006, 100 (Supplement 1) : S135-S135 . 2006; 100: 135--SAN ANTONIO BREAST SYMPOSIUM ; DEC 14–17, 2006; San Antonio, USA.
[Poster]
Peintinger, F.; Whitman, GJ ; Stephens, TW ; Anderson, K ; Phelps, M ; Symmans, WF
Predicting residual tumor size in breast cancer patients treated with neoadjuvant chemotherapy: do we need mammography or sonography or both modalities?
BREAST CANCER RESEARCH AND TREATMENT 2006, 100 (Supplement 1): S126-S126 . 2006; 10: 126--SAN ANTONIO BREAST SYMPOSIUM; DEC14–17, 2006; San Antonio, USA.
[Poster]
Perschler, M; Eichhorn, Peintinger, Tammaa, A; Mirna, A; Ralph, G; Salzer, H;
Erste Erfahrungen mit Netzinterponaten bei Patientinnen mit hochgradigem Prolaps uteri oder Prolaps des Scheidenblindsackes
Geburtsh. Frauenheilk.. 2006; -Jahrestagung der ÖGGG; Jun, 2006; Villach, AUSTRIA.
[Oral Communication]
Stranzl H, Peintinger F, Ofner P
Relapse rates and patient outcome in breast cancer patients with 1-3 positive axillary lymph nodes. Is there an impact of axillary extracapsular extension (ECE) on local and/or distant control?
Eur J Cancer 2006; 4: 99--5th Eropean Breast Cancer Conference; 21.-25. März 2006; Nizza, Frankreich.
[Poster]
Symmans, W; Peintinger, F ; Hatzis, C ; Kuerer, H ; Valero, V , ; Hennessy, B ; Green, M ; Singletary, E ; Hortobagyi, G ; Pusztai, L
A new measurement of residual cancer burden to predict survival after neoadjuvant chemotherapy.
JOURNAL OF CLINICAL ONCOLOGY 2006, 24 (18): 12S
(June 20 Supplement). 2006; 24(18):12S--Annual Meeting American Society of Clinical Oncology; JUN 2 - 6, 2006; Atlanta.
[Poster]
Peintinger, F; Ralph, G; Stranzl, H; Georgouoopoulos, A; Ofner, O
Groin morbidity after inguinofemoral lymohadenectomy in patients with vulvar cancer
J Cancer Res and Clin Oncol2004; 130(1):127--26th German Cancer Congress; 27. Feber- 1. März 2004; Berlin.
[Poster]
Stranzl, H; Ofner, P; Peintinger, F; Hackl, A
Isolated axillary relapse in patients with breast cancer presenting axillary positive lymph nodes and extranodal tumor invasion
Tagungsband2004; 148-149.-EBCC 4 Hamburg; 16.-20. März 2004; Hamburg.
[Poster]
Stranzl, H; Ofner, P; Peintinger, F; Prettenhofer, U; Mayer, R; Hackl, A
Lokoregionäre Rezidivrate und Fernmetasierung bei 274 Patientinnen mit Mammakarzinom und 1-3 positiven axillären Lymphknoten +/- extrakapsulärer Ausbreitung
Tagungsband ÖGRO2004; -ÖGRO 2004; 14.-15. Oktober 2004; Wien.
[Oral Communication]
Peintinger, F; Reitsamer, R; Stranzl, H
Does radiotherapy affect arm/shoulder morbidity after sentinel node biopsy in breast cancer patients?
Eur Surg2003; 35(192):9-9.-Jahrestagung der österr. Gesellschaft für Senologie; 25.-27. September 2003; Wien.
[Oral Communication]
Stranzl, H; Ofner, P; Peintinger, F; Mayer, R; Prettenhofer, U; Hackl A
Patientinnen mit Mammakarzinom, T1-T3, 1-3 positive axilläre Lymphknoten: Das lokoregionäre Rezidiv nach postoperativer Bestrahlung mit 2 tangentialen Stehfeldern ohne separates nodales Feld
Euro Surg 2003; 35(S 19):15-15.-Jahrestagung der österr. Gesellschaft für Senologie, Schwerpunktsymposium der AG chirurgische Onkologie; 25.-27. September 2003; Wien.
[Oral Communication]
Stranzl, H; Peintinger, F; Ofner, P; Mayer, R; Prettenhofer, U; Hackl, A
Das Lymphknotenrezidiv bei Patientinnen mit Mammakarzinom und 1-3 postiven axillären Lymphknoten nach postoperativer Bestrahlung
Tagungsband ÖGRO2003; 7-7.-20. Jahrestagung ÖGRO; 20.-22. November 2003; Linz.
[Oral Communication]
Greimel, ER; Thiel, I; Peintinger, F; Cegnar, I; Pongratz, E
Proxy-ratings versus self-ratings in assessing the quality of life of women with gynecological cancer
; JUN 17-21; Missillac, France . 2002.
[Oral Communication]
Stranzl, H; Peintinger, F; Mayer, R; Prettenhofer, U; Guss, H; Hackl, A
Uncommon cancer of the breast - Experiences in Graz
STRAHLENTHER ONKOL 2002 178: 27-27.
Web of Science
Peintinger, F; Reitsamer, R; Piswanger, C; Stranzl, H
Quality of life and arm mobility after axillary lymph node dissection versus sentinel lymph node biopsy.
BREAST CANCER RES TREAT 2001 69: 220-220.
Web of Science
Peintinger, F; Thiel, I; Cegnar, A; Pongratz, Greimel, E
Lebensqualität von Frauen mit Mammakarzinom im Vergleich zu Frauen mit gynäkologischen Karzinomen
Jahrestagung der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe; JUN 24-26; Baden, AUSTRIA. 2001.
[Oral Communication]